These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32178472)

  • 1. PETRA: Drug Engineering via Rigidity Analysis.
    Herr S; Myers-Dean J; Read H; Jagodzinski F
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32178472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pocket extraction on proteins via the Voronoi diagram of spheres.
    Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
    J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MB-Isoster: A software for bioisosterism simulation.
    Elias TC; de Oliveira HCB; da Silveira NJF
    J Comput Chem; 2018 Nov; 39(29):2481-2487. PubMed ID: 30318630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational prediction of drug-target interactions in medicinal chemistry.
    González-Díaz H
    Curr Top Med Chem; 2013; 13(14):1619-21. PubMed ID: 23889056
    [No Abstract]   [Full Text] [Related]  

  • 6. Scoring functions for prediction of protein-ligand interactions.
    Wang JC; Lin JH
    Curr Pharm Des; 2013; 19(12):2174-82. PubMed ID: 23016847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the Rational Design for Polypharmacology Drug.
    Zhou J; Li Q; Wu M; Chen C; Cen S
    Curr Pharm Des; 2016; 22(21):3182-9. PubMed ID: 26907948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of drug target proteins by 2D ligand matching approach.
    Feng J; Guo H; Wang J; Lu T
    Chem Biol Drug Des; 2014 Feb; 83(2):174-82. PubMed ID: 24034065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes.
    Mortier J; Rakers C; Bermudez M; Murgueitio MS; Riniker S; Wolber G
    Drug Discov Today; 2015 Jun; 20(6):686-702. PubMed ID: 25615716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relating protein pharmacology by ligand chemistry.
    Keiser MJ; Roth BL; Armbruster BN; Ernsberger P; Irwin JJ; Shoichet BK
    Nat Biotechnol; 2007 Feb; 25(2):197-206. PubMed ID: 17287757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational resources for protein modelling and drug discovery applications.
    Dhaliwal B; Chen YW
    Infect Disord Drug Targets; 2009 Nov; 9(5):557-62. PubMed ID: 19594423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network predicting drug's anatomical therapeutic chemical code.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2013 May; 29(10):1317-24. PubMed ID: 23564845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Drug-Target Interactions with Decision Templates.
    Yan XY; Zhang SW
    Curr Protein Pept Sci; 2018; 19(5):498-506. PubMed ID: 27829344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR screening in drug discovery.
    Moore JM
    Curr Opin Biotechnol; 1999 Feb; 10(1):54-8. PubMed ID: 10047510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydration properties of ligands and drugs in protein binding sites: tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies.
    García-Sosa AT
    J Chem Inf Model; 2013 Jun; 53(6):1388-405. PubMed ID: 23662606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
    Lu S; Ji M; Ni D; Zhang J
    Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoproteomics: Towards Global Drug Target Profiling.
    Lu KY
    Chembiochem; 2020 Nov; 21(22):3189-3191. PubMed ID: 32935403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.